Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models
- PMID: 29554472
- PMCID: PMC5862043
- DOI: 10.1177/0272989X17737507
Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models
Abstract
The Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Working Group is a consortium of National Cancer Institute-sponsored investigators who use statistical and simulation modeling to evaluate the impact of cancer control interventions on long-term population-level breast cancer outcomes such as incidence and mortality and to determine the impact of different breast cancer control strategies. The CISNET breast cancer models have been continuously funded since 2000. The models have gone through several updates since their inception to reflect advances in the understanding of the molecular basis of breast cancer, changes in the prevalence of common risk factors, and improvements in therapy and early detection technology. This article provides an overview and history of the CISNET breast cancer models, provides an overview of the major changes in the model inputs over time, and presents examples for how CISNET breast cancer models have been used for policy evaluation.
Keywords: breast cancer control; breast cancer epidemiology; cancer simulation; simulation models.
Similar articles
-
Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.PLoS Comput Biol. 2021 Jun 17;17(6):e1009020. doi: 10.1371/journal.pcbi.1009020. eCollection 2021 Jun. PLoS Comput Biol. 2021. PMID: 34138842 Free PMC article. Review.
-
Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.Med Decis Making. 2018 Apr;38(1_suppl):9S-23S. doi: 10.1177/0272989X17700624. Med Decis Making. 2018. PMID: 29554466 Free PMC article.
-
Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.Med Decis Making. 2018 Apr;38(1_suppl):126S-139S. doi: 10.1177/0272989X17729358. Med Decis Making. 2018. PMID: 29554463 Free PMC article.
-
Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.Med Decis Making. 2018 Apr;38(1_suppl):112S-125S. doi: 10.1177/0272989X17743244. Med Decis Making. 2018. PMID: 29554471 Free PMC article.
-
Diversity of model approaches for breast cancer screening: a review of model assumptions by the Cancer Intervention and Surveillance Network (CISNET) Breast Cancer Groups.Stat Methods Med Res. 2004 Dec;13(6):525-38. doi: 10.1191/0962280204sm381ra. Stat Methods Med Res. 2004. PMID: 15587437 Review.
Cited by
-
Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.PLoS Comput Biol. 2021 Jun 17;17(6):e1009020. doi: 10.1371/journal.pcbi.1009020. eCollection 2021 Jun. PLoS Comput Biol. 2021. PMID: 34138842 Free PMC article. Review.
-
Simulation modeling approaches to answer clinically relevant questions in breast cancer low-risk populations.Ann Transl Med. 2018 Nov;6(Suppl 1):S80. doi: 10.21037/atm.2018.10.68. Ann Transl Med. 2018. PMID: 30613655 Free PMC article. No abstract available.
-
Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.J Gen Intern Med. 2019 Nov;34(11):2374-2381. doi: 10.1007/s11606-019-05182-5. Epub 2019 Aug 5. J Gen Intern Med. 2019. PMID: 31385214 Free PMC article.
-
Discrete-Event Simulation Model for Cancer Interventions and Population Health in R (DESCIPHR): An Open-Source Pipeline.medRxiv [Preprint]. 2025 May 13:2025.05.12.25327470. doi: 10.1101/2025.05.12.25327470. medRxiv. 2025. PMID: 40463521 Free PMC article. Preprint.
-
Optimal breast cancer risk reduction policies tailored to personal risk level.Health Care Manag Sci. 2022 Sep;25(3):363-388. doi: 10.1007/s10729-022-09596-2. Epub 2022 Jun 10. Health Care Manag Sci. 2022. PMID: 35687269 Free PMC article.
References
-
- Screening IUPoBC. The benefits and harms of breast cancer screening: an independent review. The Lancet. 2012;380(9855):1778–1786. - PubMed
-
- Stewart B, Wild CP. World cancer report 2014. World. 2015
-
- Sox HC, Greenfield S. Comparative effectiveness research: a report from the Institute of Medicine. Annals of Internal Medicine. 2009;151(3):203–205. - PubMed
-
- Sox HC. Quality of life and guidelines for PSA screening. New England Journal of Medicine. 2012;367(7):669–671. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical